Philippe Unger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Philippe Unger has a total of 193 co-authors. Here are the top co-authors by number of shared publications:
Aurelia David-Cojocariu
Cardiology Department, CHU Saint-Pierre , 322 rue Haute, Université Libre de Bruxelles (ULB), B-1000 Brussels
8 shared publicationsDidier de Cannière
Department of Cardiac Surgery, CHU Saint-Pierre, Université Libre de Bruxelles , Brussels , Belgium
7 shared publications- Quentin de Hemptinne
Department of Cardiology, CHU Saint-Pierre, Université Libre de Bruxelles, 105 Rue Aux Laines, 1000, Brussels, Belgium
7 shared publications - Xavier Galloo
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
7 shared publications Quentin de Hemptinne
Centre Hospitalier Universitaire Saint-Pierre, Department of Cardiology, Université Libre de Bruxelles (ULB), Brussels, Belgium
5 shared publicationsEric Stoupel
Department of Cardiology, Université Libre de Bruxelles (ULB), Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium
4 shared publications
Latest Publications
- Open Access
- 26 February 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (2)
Right Ventricular Function in Patients With Significant Tricuspid Regurgitation
Significant tricuspid regurgitation (TR) is increasingly recognized as a major determinant of morbidity and mortality, yet the clinical impact of significant TR has long been underestimated. Assessment of right ventricular (RV) systolic function is central to understanding and managing TR and represents the principal determinant of symptoms, therapeutic response, and long-term outcomes. The unique sensitivity of the RV to alterations in preload and afterload leads to maladaptive remodeling, making accurate functional assessment essential for risk stratification and for optimizing the timing and type of intervention, especially given the expanding range of available surgical and transcatheter treatment options. Echocardiography remains the primary imaging modality, providing qualitative and quantitative evaluations of RV function through parameters such as tricuspid annular plane systolic excursion (TAPSE), RV fractional area change (RVFAC), and tissue Doppler systolic velocity (S′). Advances in speckle-tracking echocardiography for RV free-wall longitudinal strain and in three-dimensional imaging have improved accuracy; however, all echocardiographic measures remain limited by the complex geometry of the RV. When feasible and available, cardiac magnetic resonance (CMR) imaging serves as the reference standard for precise assessment of RV volumetric and functional parameters. Impaired RV systolic function, both before and after intervention, irrespective of the imaging parameter used for the assessment, consistently predicts adverse outcomes in patients with severe TR, including heart failure progression, reduced exercise tolerance, and decreased survival. Therefore, early recognition and quantification of RV dysfunction are crucial to enable timely therapy, as interventions before the development of advanced RV impairment provide symptomatic and survival benefits. This review summarizes the pathophysiology, quantitative thresholds, and prognostic significance of RV function assessment, emphasizing the pivotal role this evaluation plays in the contemporary management of significant TR.
- 26 February 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (2)
Open AccessRight Ventricular Function in Patients With Significant Tricuspid Regurgitation
Significant tricuspid regurgitation (TR) is increasingly recognized as a major determinant of morbidity and mortality, yet the clinical impact of significant TR has long been underestimated. Assessment of right ventricular (RV) systolic function is central to understanding and managing TR and represents the principal determinant of symptoms, therapeutic response, and long-term outcomes. The unique sensitivity of the RV to alterations in preload and afterload leads to maladaptive remodeling, making accurate functional assessment essential for risk stratification and for optimizing the timing and type of intervention, especially given the expanding range of available surgical and transcatheter treatment options. Echocardiography remains the primary imaging modality, providing qualitative and quantitative evaluations of RV function through parameters such as tricuspid annular plane systolic excursion (TAPSE), RV fractional area change (RVFAC), and tissue Doppler systolic velocity (S′). Advances in speckle-tracking echocardiography for RV free-wall longitudinal strain and in three-dimensional imaging have improved accuracy; however, all echocardiographic measures remain limited by the complex geometry of the RV. When feasible and available, cardiac magnetic resonance (CMR) imaging serves as the reference standard for precise assessment of RV volumetric and functional parameters. Impaired RV systolic function, both before and after intervention, irrespective of the imaging parameter used for the assessment, consistently predicts adverse outcomes in patients with severe TR, including heart failure progression, reduced exercise tolerance, and decreased survival. Therefore, early recognition and quantification of RV dysfunction are crucial to enable timely therapy, as interventions before the development of advanced RV impairment provide symptomatic and survival benefits. This review summarizes the pathophysiology, quantitative thresholds, and prognostic significance of RV function assessment, emphasizing the pivotal role this evaluation plays in the contemporary management of significant TR.
- Open Access
- 31 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (11)
Severe aortic regurgitation with acute decompensation as initial presentation of Behçet’s syndrome: a case report
Background: Behçet’s syndrome (BS) is a rare, chronic multisystem inflammatory disorder that can lead to severe cardiovascular complications. Among these, aortic pseudoaneurysms are infrequent and associated with high mortality due to their risk of rupture. The diagnosis of BS remains challenging due to its variable clinical presentation and the absence of specific biomarkers, particularly when the initial presentation is atypical. Case summary: We present the case of a 32-year-old former professional football player who presented with severe aortic regurgitation with heart failure due to a pseudoaneurysm of the ascending aorta. Initial suspicion of infective endocarditis and aortic dissection was excluded after a clinical, microbiological, and imaging assessment. Emergent Bentall procedure was successfully performed. Subsequently, typical clinical features, including recurrent oral ulcers, pseudofolliculitis, and superficial venous thrombophlebitis, led to the diagnosis of BS. The patient received systemic immunosuppressive therapy combining corticosteroids and infliximab. At 8-month follow-up, echocardiography demonstrated normalization of left ventricular function and no recurrence or new vascular involvement. Discussion: The case highlights the importance of considering BS in the differential diagnosis of young patients presenting with acute aortic disease. Aortic involvement in BS, although rare, can lead to severe complications. To the best of our knowledge, this is the first reported case of a pseudoaneurysm of the aortic root as the initial manifestation of BS. Rapid surgical intervention followed by appropriate medical therapy led to a favourable outcome. Recognizing BS as a potential cause of acute presentations of ascending aortic disease may ensure early and effective management.
- 31 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (11)
Open AccessSevere aortic regurgitation with acute decompensation as initial presentation of Behçet’s syndrome: a case report
Background: Behçet’s syndrome (BS) is a rare, chronic multisystem inflammatory disorder that can lead to severe cardiovascular complications. Among these, aortic pseudoaneurysms are infrequent and associated with high mortality due to their risk of rupture. The diagnosis of BS remains challenging due to its variable clinical presentation and the absence of specific biomarkers, particularly when the initial presentation is atypical. Case summary: We present the case of a 32-year-old former professional football player who presented with severe aortic regurgitation with heart failure due to a pseudoaneurysm of the ascending aorta. Initial suspicion of infective endocarditis and aortic dissection was excluded after a clinical, microbiological, and imaging assessment. Emergent Bentall procedure was successfully performed. Subsequently, typical clinical features, including recurrent oral ulcers, pseudofolliculitis, and superficial venous thrombophlebitis, led to the diagnosis of BS. The patient received systemic immunosuppressive therapy combining corticosteroids and infliximab. At 8-month follow-up, echocardiography demonstrated normalization of left ventricular function and no recurrence or new vascular involvement. Discussion: The case highlights the importance of considering BS in the differential diagnosis of young patients presenting with acute aortic disease. Aortic involvement in BS, although rare, can lead to severe complications. To the best of our knowledge, this is the first reported case of a pseudoaneurysm of the aortic root as the initial manifestation of BS. Rapid surgical intervention followed by appropriate medical therapy led to a favourable outcome. Recognizing BS as a potential cause of acute presentations of ascending aortic disease may ensure early and effective management.
- 29 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (43) , 4619
Role of contrast-enhanced echocardiography in the management of periaortic pseudoaneurysm: mind the gap
- 29 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (43) , 4619
Role of contrast-enhanced echocardiography in the management of periaortic pseudoaneurysm: mind the gap
- 19 May 2025
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 80 (6) , 674-678
Low-gradient normal-flow aortic stenosis: don’t forget the assessment of the flow rate
- 19 May 2025
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 80 (6) , 674-678
Low-gradient normal-flow aortic stenosis: don’t forget the assessment of the flow rate
- 11 April 2025
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 38 (7) , 638
Indexing Tricuspid Annular Systolic Plane Excursion to Right Ventricular Length as a Surrogate of Right Ventricular Free Wall Strain
- 11 April 2025
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 38 (7) , 638
Indexing Tricuspid Annular Systolic Plane Excursion to Right Ventricular Length as a Surrogate of Right Ventricular Free Wall Strain
- Open Access
- 1 April 2025
- Published by SAGE Publications in Journal of the Heart Valve Society
- Vol. 2 (2) , 158-168
Antithrombotic Therapy in Infective Endocarditis: A Retrospective Analysis of Mortality and Complications
Purpose: Thromboembolism (TE) arises in 20% to 50% of patients with infective endocarditis (IE), significantly contributing to mortality. While the pathogenesis of IE includes the formation of vegetations with platelet-fibrin clots, antithrombotic therapy (AT) has not consistently shown to prevent TE. Moreover, because of the increased risk of cerebral hemorrhage, guidelines advise against using AT in the management of IE. However, many patients with IE already receive AT at admission due to pre-existing cardiovascular conditions. This retrospective, multicentric study aims to provide insights into the in-hospital mortality and complications of patients with IE under various regimens of pre-existing AT, compared to IE controls without AT. Methods: A total of 363 patients with IE were included at 2 tertiary hospitals in Belgium. The following groups were compared: 129 patients with IE without AT (group 1), 104 patients with IE with an antiplatelet treatment (group 2), 100 patients with IE under anticoagulant therapy (group 3), and 30 patients with IE treated with combined antiplatelet and anticoagulant agents at admission (group 4). Results: This study found no significant differences in in-hospital mortality ( P = .091), TE ( P = .413), or hemorrhagic stroke ( P = .274) between groups. There was a nonsignificant trend toward reduced vegetation size ( P = .112) in the anticoagulant-treated IE groups 3 and 4. There were significantly more viridans streptococci infections in the younger control group 1 ( P = .012). Conclusion: This analysis challenges the conventional caution against AT use in IE, suggesting that pre-existing AT does not significantly influence mortality or complications in patients with IE.
- 1 April 2025
- Published by SAGE Publications in Journal of the Heart Valve Society
- Vol. 2 (2) , 158-168
Open AccessAntithrombotic Therapy in Infective Endocarditis: A Retrospective Analysis of Mortality and Complications
Purpose: Thromboembolism (TE) arises in 20% to 50% of patients with infective endocarditis (IE), significantly contributing to mortality. While the pathogenesis of IE includes the formation of vegetations with platelet-fibrin clots, antithrombotic therapy (AT) has not consistently shown to prevent TE. Moreover, because of the increased risk of cerebral hemorrhage, guidelines advise against using AT in the management of IE. However, many patients with IE already receive AT at admission due to pre-existing cardiovascular conditions. This retrospective, multicentric study aims to provide insights into the in-hospital mortality and complications of patients with IE under various regimens of pre-existing AT, compared to IE controls without AT. Methods: A total of 363 patients with IE were included at 2 tertiary hospitals in Belgium. The following groups were compared: 129 patients with IE without AT (group 1), 104 patients with IE with an antiplatelet treatment (group 2), 100 patients with IE under anticoagulant therapy (group 3), and 30 patients with IE treated with combined antiplatelet and anticoagulant agents at admission (group 4). Results: This study found no significant differences in in-hospital mortality ( P = .091), TE ( P = .413), or hemorrhagic stroke ( P = .274) between groups. There was a nonsignificant trend toward reduced vegetation size ( P = .112) in the anticoagulant-treated IE groups 3 and 4. There were significantly more viridans streptococci infections in the younger control group 1 ( P = .012). Conclusion: This analysis challenges the conventional caution against AT use in IE, suggesting that pre-existing AT does not significantly influence mortality or complications in patients with IE.
- 27 February 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (24) , 2261-2274
Mixed valvular heart disease: diagnosis and management
Mixed valvular diseases (MVDs) are common but have received little attention in the literature, especially regarding the mitral valve (MV) and the right-sided cardiac valves. Whereas echocardiography plays a pivotal diagnostic role, the diagnosis is made difficult due to haemodynamic interactions that may invalidate common indices of severity used in isolated stenosis or regurgitation. The diagnostic strategy should aim at initially separately assessing stenosis and regurgitation, taking into account the diagnostic pitfalls, with complementary use of multimodality imaging in cases of persisting diagnostic uncertainties. Unlike aortic stenosis, the calcium score cannot be used as a surrogate for haemodynamic severity of mixed MV disease. Severe stenosis and/or severe regurgitation are indicative of severe MVD, and management should follow recommendations on the predominant lesion. However, some patients with the combination of moderate stenosis and moderate regurgitation have a poor prognosis when left untreated. Concordant data suggest that, in patients with mixed aortic or MV disease, transvalvular velocities and pressure gradients are more powerful prognostic indicators than valve area or the severity of regurgitation. It is essential to consider the global repercussions that indicate poor outcomes in patients with MVD. However, whereas symptoms and/or ventricular dysfunction are considered as clear indication for intervention, imaging cut-offs have not been validated for balanced moderate regurgitation and stenosis. Although emerging evidence tends to support earlier management, further prospective studies are required, and pending the results of these studies, asymptomatic patients with MVD should be closely monitored.
- 27 February 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (24) , 2261-2274
Mixed valvular heart disease: diagnosis and management
Mixed valvular diseases (MVDs) are common but have received little attention in the literature, especially regarding the mitral valve (MV) and the right-sided cardiac valves. Whereas echocardiography plays a pivotal diagnostic role, the diagnosis is made difficult due to haemodynamic interactions that may invalidate common indices of severity used in isolated stenosis or regurgitation. The diagnostic strategy should aim at initially separately assessing stenosis and regurgitation, taking into account the diagnostic pitfalls, with complementary use of multimodality imaging in cases of persisting diagnostic uncertainties. Unlike aortic stenosis, the calcium score cannot be used as a surrogate for haemodynamic severity of mixed MV disease. Severe stenosis and/or severe regurgitation are indicative of severe MVD, and management should follow recommendations on the predominant lesion. However, some patients with the combination of moderate stenosis and moderate regurgitation have a poor prognosis when left untreated. Concordant data suggest that, in patients with mixed aortic or MV disease, transvalvular velocities and pressure gradients are more powerful prognostic indicators than valve area or the severity of regurgitation. It is essential to consider the global repercussions that indicate poor outcomes in patients with MVD. However, whereas symptoms and/or ventricular dysfunction are considered as clear indication for intervention, imaging cut-offs have not been validated for balanced moderate regurgitation and stenosis. Although emerging evidence tends to support earlier management, further prospective studies are required, and pending the results of these studies, asymptomatic patients with MVD should be closely monitored.
- 28 January 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (4) , 593-608
The role of multi-modality imaging in multiple valvular heart diseases: a clinical consensus statement of the European Association of Cardiovascular Imaging of the European Society of Cardiology
With this document, the European Association of Cardiovascular Imaging provides an Expert Consensus on the role of multi-modality imaging (MMI) in the management of patients with multiple valvular heart disease (MVD). Emphasis is given to the use of MMI to unravel the diagnostic challenges that characterize these patients and to improve risk stratification. Complementing the last European Society of Cardiology and European Association of Cardio-Thoracic Surgery guidelines on valvular heart disease, this Expert Consensus document also outlines how MMI assessment should form an integral part of the multi-disciplinary heart team discussion for patients with MVD to help with complex decision-making regarding the choice and timing of treatment.
- 28 January 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (4) , 593-608
The role of multi-modality imaging in multiple valvular heart diseases: a clinical consensus statement of the European Association of Cardiovascular Imaging of the European Society of Cardiology
With this document, the European Association of Cardiovascular Imaging provides an Expert Consensus on the role of multi-modality imaging (MMI) in the management of patients with multiple valvular heart disease (MVD). Emphasis is given to the use of MMI to unravel the diagnostic challenges that characterize these patients and to improve risk stratification. Complementing the last European Society of Cardiology and European Association of Cardio-Thoracic Surgery guidelines on valvular heart disease, this Expert Consensus document also outlines how MMI assessment should form an integral part of the multi-disciplinary heart team discussion for patients with MVD to help with complex decision-making regarding the choice and timing of treatment.
- 17 January 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (5) , 933
Unveiling type B aortic dissection in Loeys–Dietz syndrome by transthoracic echocardiography: back to the root
- 17 January 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (5) , 933
Unveiling type B aortic dissection in Loeys–Dietz syndrome by transthoracic echocardiography: back to the root
- 9 January 2025
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 74 (1) , 101853
Pseudo-anévrisme du trigone mitro-aortique : cas clinique et revue de littérature
- 9 January 2025
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 74 (1) , 101853
Pseudo-anévrisme du trigone mitro-aortique : cas clinique et revue de littérature